Telormedix SA
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study With TMX-101 in Patients With Carcinoma In Situ (CIS) Bladder Cancer (NCT01731652) | Telormedix SA | 2013-02-01 |
Track Telormedix SA automatically
Every clearance here is in the API, with alerts when new ones post.